To evaluate the safety and efficacy of twice daily dosing and once daily dosing of YM150 in subjects undergoing primary elective knee replacement surgery
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
685
The incidence of total venous thromboembolisms (VTE).
Time frame: 6 Weeks
The incidence of bleeding events classified as major by the Adjudication Committee
Time frame: 6 Weeks
Evaluation of efficacy variables including: Proximal VTE, Distal VTE, Confirmed symptomatic VTE, death due to any cause
Time frame: 6 Weeks
Incidence of the bleeding types: major, clinically relevant nonmajor, minor
Time frame: 6 Weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Unnamed facility
Mobile, Alabama, United States
Unnamed facility
Phoenix, Arizona, United States
Unnamed facility
Tuscon, Arizona, United States
Unnamed facility
Little Rock, Arkansas, United States
Unnamed facility
Fountain Valley, California, United States
Unnamed facility
La Mesa, California, United States
Unnamed facility
Long Beach, California, United States
Unnamed facility
Long Beach, California, United States
Unnamed facility
San Diego, California, United States
Unnamed facility
Santa Ana, California, United States
...and 44 more locations